RUSNANO's investment will leverage synergies between Quantenna's portfolio and a number of nanotechnology initiatives that are underway at RUSNANO, whose mission is to develop the Russian nanotechnology industry through a variety of co-investment opportunities.
Available now, fully depleted wafers from Soitec, pre-integrate critical characteristics of the transistor within the wafer structure itself. Soitec's fully depleted wafers offer an early, low-risk migration at the 28nm node down to 10nm and beyond, lowering costs and enabling significant advances in the performance and power efficiency of mobile devices such as smartphones and tablets.
The government of Canada today announced a repayable government investment of $399,386 in a project by Integran Technologies Inc. The Mississauga-based company is developing innovative nano-structured aerospace and defence products that will offer superior performance while meeting the highest environmental standards.
Used to create thin film coatings for the optical market, the SPECTOR-HT provides up to 400% increase in throughput, 300% increase in target utilization and 50% improvement in material uniformity compared to previous SPECTOR generations.
ARM today announced the availability of a significantly expanded lineup of ARM Processor Optimization Pack solutions for TSMC 40nm and 28nm process technologies targeting a range of ARM Cortex processors.
After a worldwide search for a premier location, Entegris, a Billerica-based supplier to the semiconductor and microelectronics industries, announced today its plans to create the Entegris i2M Center for Advanced Materials Science in Bedford, Massachusetts.
RUSNANO has invested 25 million euros in Beneq, the Finnish pioneer and world-leader in industrial production and laboratory equipment for nano-scale thin films and functional coatings. The investment is a combination of capital injection and share purchase.
Haydale, a wholly owned subsidiary of British company Innovative Carbon Limited, today announces that they have reached a collaboration agreement with leading German Plasma reactor manufacturer, Diener electronic GmbH. The unique Split-Plasma reactor will be built jointly under the arrangement that will allow both partners to market the machine as part of the commercialisation of the Haydale Split-Plasma nano materials to be sold under the brand HDPlas.
Arrowhead Research Corporation, a nanomedicine company with development programs in RNA therapeutics and obesity, today announced that it has acquired Alvos Therapeutics, Inc. (formerly known as Mercator Therapeutics, Inc.), a privately-held company that licensed a large platform of proprietary human-derived homing peptides from MD Anderson Cancer Center (MDACC) and the method for their discovery.